Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphomaDaria Zdżalik-Bielecka, Karolina Dzwonek|Journal of Cancer Research and Clinical Oncology|2014Cited by 36